You are here

Mydecine Innovations Group Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
MYCO
CSE Index: 
Currency: 

Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions.

You are here

Mydecine Innovations Group Inc. (MYCO)

SEDAR Information

Company Info

Address
789 W Pender Street, Suite 810
Vancouver, BC V6C 1H2
Canada
Phone
604-687-2038
Email
contact@mydecineinc.com
Website
http://www.mydecineinc.com
Listing date
Monday, August 18, 2014
Transfer Agent
National Securities Administrators Ltd.
Investor Relations
D. Joshua Bartch
Email
contact@mydecineinc.com
Auditor
Adam Sung Kim Ltd.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
166,520,845
Reserved for Issuance: 
51,854,217

Bulletins

02/06/2020

2020-0603 – Name and Symbol Change - NewLeaf Brands Inc. (NLB)

Le 2 juin/June 2020

NewLeaf Brands Inc. has announced a name and symbol change to Mydecine Innovations Group Inc. (MYCO).

Shares will begin trading under the new name and symbol on June 5, 2020.

Disclosure documents are available at www.thecse.com

Please note that all open orders will be cancelled at the end of business on June 4, 2020. Dealers are reminded to re-enter their orders.

________________________

Advertisement

Publicité

Latest CSE News

Upcoming Events

2020-10-21-Cannabis-and-Tech_Website.jpg

Cannabis + Technology

Wednesday, October 21, 2020 - 9:30am to Thursday, October 22, 2020 - 7:00pm
ipP_rRhg_1.png

Mining Over Canada

Tuesday, November 24, 2020 -
1:00pm to 4:00pm